Resultados y expectativas por inmunoterapias: linfoma, asma, neurología, virus sincitial respiratorio

– Bispecific antibodies for the treatment of B-cell lymphoma: promises, unknowns, and opportunities. Blood, 2023;141(5):467–480.
– Efficacy of dupilumab in patients with moderate-to-severe asthma and persistent airflow obstruction. Annals of Allergy, Asthma & Immunology, February 2023;130(2):206-214.e2.
– Intranasal delivery of full-length anti-Nogo-A antibody: A potential alternative route for therapeutic antibodies to central nervous system targets. Proc Natl Acad Sci U S A, 2023;120(4):e2200057120.
– Monoclonal Antibody for the Prevention of Respiratory Syncytial Virus in Infants and Children. A Systematic Review and Network Meta-analysis. JAMA Netw Open. 2023;6(2):e230023.